Published in Eur J Cancer on September 01, 1998
Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol (2000) 1.33
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology (2008) 1.12
Impact of differential cyclin D1 expression and localisation in prostate cancer. Br J Cancer (2007) 1.09
Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study. Biol Sex Differ (2011) 1.04
A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res (2009) 1.02
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol (2005) 1.02
Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies. PLoS One (2014) 1.00
A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis (2005) 0.95
Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon. Proc Natl Acad Sci U S A (2008) 0.93
Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study. Oncol Lett (2013) 0.85
PAX2 protein induces expression of cyclin D1 through activating AP-1 protein and promotes proliferation of colon cancer cells. J Biol Chem (2012) 0.83
Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World J Surg Oncol (2006) 0.82
Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. Int J Colorectal Dis (2011) 0.80
Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis. PLoS One (2014) 0.76
[Clinical, pathological and molecular prognostic factors in colorectal carcinomas]. Pathologe (2003) 0.75
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Expression of vascular endothelial growth factor protein in human renal cell carcinoma. BJU Int (2004) 1.79
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. J Clin Pathol (2008) 1.79
Low folate levels may protect against colorectal cancer. Gut (2006) 1.60
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J (1988) 1.51
Lateral rectal ligaments contain important nerves. Br J Surg (1997) 1.47
Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia (1993) 1.40
Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery. Colorectal Dis (2006) 1.39
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
Colonic endocrine cells in inflammatory bowel disease. J Intern Med (1997) 1.35
Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol (2000) 1.33
Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene (1997) 1.33
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol (2003) 1.31
Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer (2009) 1.29
Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol (1988) 1.24
Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia (1993) 1.23
Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci (2007) 1.21
A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochem Biophys Res Commun (1995) 1.20
Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer (1996) 1.19
Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum (1998) 1.17
Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol (1995) 1.17
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis. J Cell Sci (1993) 1.15
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis (2002) 1.13
Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization. J Pathol (1999) 1.10
COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10
G1-S transition defects occur in most breast cancers and predict outcome. Breast Cancer Res Treat (1999) 1.10
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer. J Pathol (2009) 1.09
Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood (1998) 1.08
Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol (1999) 1.08
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol (2005) 1.07
Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol (1993) 1.07
Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies. Lab Invest (1993) 1.05
Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J Neurochem (1997) 1.04
A simple index for assessment of disease activity in patients with ulcerative colitis. Hepatogastroenterology (1990) 1.03
Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis (1999) 1.01
P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis (1995) 1.01
Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer (1999) 1.00
Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence. Br J Cancer (2003) 1.00
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer (2003) 1.00
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res (2000) 1.00
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol (2011) 0.97
Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer (1987) 0.97
Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer. Cancer Lett (2001) 0.97
Determination of the epitope of an inhibitory antibody to proliferating cell nuclear antigen. Exp Cell Res (1996) 0.97
Stereological studies on the small intestinal epithelium of the rat. 1. The absorptive cells of the normal duodenum and jejunum. Cell Tissue Res (1981) 0.96
Mechanical manipulation of bone and cartilage cells with 'optical tweezers'. FEBS Lett (1999) 0.95
DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer (1985) 0.94
Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer (1999) 0.94
Cyclin-D1 expression in human renal-cell carcinoma. Int J Cancer (1999) 0.92
Cyclin E expression and proliferation in breast cancer. Anal Cell Pathol (1998) 0.91
Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas. Leuk Lymphoma (2001) 0.90
Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. Br J Cancer (1998) 0.90
Parity in relation to survival following breast cancer. Eur J Surg Oncol (2008) 0.89
Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation. Oncogene (1999) 0.89
p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer (1995) 0.89
Heterogeneity in renal cell carcinoma and its impact no prognosis--a flow cytometric study. Br J Cancer (1996) 0.88
Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. Br J Cancer (2006) 0.88
Rearrangements of minisatellites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene (2001) 0.88
Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg (1994) 0.87
Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model. J Mol Cell Cardiol (1986) 0.87
A population based cohort study of patients with multiple colon and endometrial cancer: correlation of microsatellite instability (MSI) status, age at diagnosis and cancer risk. Int J Cancer (2001) 0.86
Immunohistochemical markers for Barrett's esophagus and associations to esophageal Z-line appearance. Scand J Gastroenterol (2001) 0.86
The Z-line appearance and prevalence of intestinal metaplasia among patients without symptoms or endoscopical signs indicating gastroesophageal reflux. Surg Endosc (2001) 0.86
Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus. Histopathology (2005) 0.85
The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia. Scand J Gastroenterol (2000) 0.85
DNA content in ulcerative colitis. Flow cytometric analysis in a patient series from a defined area. Dis Colon Rectum (1988) 0.85
Factors influencing the estimates of proliferative labelling indices in rectal cancer. Radiother Oncol (1998) 0.85
Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer. Int J Cancer (1998) 0.85
Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma. Mod Pathol (1999) 0.85
Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer. Br J Surg (2011) 0.84
Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys (1997) 0.84
Long-term cultured IL-2-dependent T cell lines demonstrate p16(INK4a) overexpression, normal pRb/p53, and upregulation of cyclins E or D2. Exp Gerontol (2000) 0.83
Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut (1991) 0.83
Morphologic changes in the small intestine after chronic alcohol consumption. Scand J Gastroenterol (1990) 0.83
Tumour-related factors and prognosis in breast cancer detected by screening. Br J Surg (2011) 0.82
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. Int J Oncol (1998) 0.82
Gingival blood flow and temperature changes in young humans with a history of periodontitis. Arch Oral Biol (1990) 0.82
Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma. Oncology (2000) 0.82
Mechanical manipulation of polymorphonuclear leukocyte plasma membranes with optical tweezers causes influx of extracellular calcium through membrane channels. Med Biol Eng Comput (1999) 0.82
Prognosis after early onset of ulcerative colitis. A study from an unselected patient population. Hepatogastroenterology (1993) 0.82
Prognostic significance of the DNA content in renal cell carcinoma. J Urol (1986) 0.82
Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut (1994) 0.81
[Population-based biological test bank. New possibilities for epidemiologic cancer research]. Lakartidningen (1991) 0.81
Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol (2000) 0.81
Transcriptional upregulation and unmethylation of the promoter region of p16 in invasive basal cell carcinoma cells and partial co-localization with the gamma 2 chain of laminin-332. J Pathol (2007) 0.80
Adhesion of bacteria to the human small-intestinal mucosa. A scanning electron microscopic study. Scand J Gastroenterol (1989) 0.80
Bacterial contamination of the small bowel evaluated by breath tests, 75Se-labelled homocholic-tauro acid, and scanning electron microscopy. Scand J Gastroenterol (1990) 0.80